Paper
0
Impact of Prior Bendamustine Exposure on Bispecific Antibody Treatment Outcomes in Patients with Relapsed/Refractory Follicular Lymphoma
Authors
Gloria Iacoboni,Emil Kyvsgaard
Victor Garces,David Russler‐Germain,Alejandro Martı́n,Philip Thompson,Dylan Therwhanger,Itziar Carro,David Quintela,Pilar Gómez,Evelyn Valencia,Gala Vega,Ana Ubieto,Mariana Bastos‐Oreiro,Ángel Serna,Simon Husby,Beatriz Cruz,Jing Luan,Sergi Camarillas,Lucía Medina,Almudena Cabero,Raúl Córdoba,Miguel Canales,Francesc Bosch,Juan‐Manuel Sancho,Anna Balari,Stephen Schuster,Martin Hutchings,Pere Barba,Pau Costa,Alejandro Martín
+29 authors
,Ana Jiménez‐UbietoJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.